|
|
|
|
|
|
Bristol-Myers Squibb Company (BMY)
|
|
57.87 +0.20 (+0.35%)
|
8/23/2017 4:03pm
|
|
Open:
|
57.63
|
Pre. Close:
|
57.67
|
|
High:
|
58.17
|
Low:
|
57.43
|
|
Volume:
|
4,017,279
|
Market Cap:
|
94.90B
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
58.26 - 58.66
|
58.66 - 59.15
|
|
Low:
|
56.42 - 56.83
|
56.83 - 57.34
|
|
Close:
|
57.15 - 57.78
|
57.78 - 58.55
|
|
|
|
|
|
|
Technical analysis (as of: 2017-08-23 4:41:20 PM)
|
|
Overall:
|
|
|
Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.
|
|
Target:
|
Six months: 67.94  One year: 79.36
|
|
Support:
|
Support1: 54.39 Support2: 52.06
|
|
Resistance:
|
Resistance1:
58.17 Resistance2: 67.94
|
|
Pivot:
|
56.92
|
|
Moving Averages:
|
MA(5): 57.07 MA(20): 56.57
MA(100): 55.03 MA(250): 55.00 
|
|
MACD:
|
MACD(12,26):
0.49 Signal(12,26,9): 0.44
|
|
%K %D:
|
%K(14,3): 77.63 %D(3): 65.68
|
|
RSI:
|
RSI(14): 59.99
|
|
52-Week:
|
High: 60.45
Low: 46.01 Change(%): -1.5
|
|
Average Vol(K):
|
3-Month: 696943
10-Days 378623
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.BMY has closed below upper band by 15.7%. Bollinger Bands are 14.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
Tue, 22 Aug 2017 19:41:15 GMT
What's Next for Bristol-Myers Squibb After Its Opdivo Setback?
Tue, 08 Aug 2017 16:41:15 GMT
Bristol-Myers Squibb plans 58 layoffs as drug patents expire
Wed, 16 Aug 2017 17:15:00 GMT
Bristol-Myers Squibb Combination Treatment Not At The End Of The Crossroad
Tue, 22 Aug 2017 11:37:30 GMT
Rnc Capital Management Llc Buys Bristol-Myers Squibb Company, General Mills ...
Thu, 27 Jul 2017 16:41:15 GMT
Why Bristol-Myers Squibb Co (BMY) Shares Are Sinking Today
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
